Melanotan II 10mg Pen Bali | Atlas Longevity

Price range: Rp1,500,000.00 through Rp2,100,000.00 ~$90.91–$127.27

Melanotan II 10mg Pen from Atlas Longevity provides Melanotan II in our premium, convenient 3ml Atlas Pen format.

Melanotan II is a synthetic melanocortin analogue researched for its interaction with melanocortin receptors involved in pigmentation, sexual signalling and other physiological pathways.

✓ 10mg Melanotan II
✓ Premium Atlas Pen format
✓ 3ml / 300-unit cartridge
✓ Precision dial mechanism
✓ Quality-controlled sourcing
✓ COA available where applicable
✓ Discreet packaging
✓ Fast delivery across Bali

For research purposes only. Not intended to diagnose, treat, cure or prevent any medical condition.

10 Needles + 10 Alcohol pads included.
Description

Melanotan II 10 mg Pen

Product Description

Melanotan II (MT-II) is a synthetic cyclic analogue of alpha-melanocyte-stimulating hormone (α-MSH) studied for its effects on melanocortin receptors, melanogenesis, pigmentation, appetite-related signalling, sexual-function pathways, and neuroendocrine regulation.

Unlike more selective melanocortin analogues, Melanotan II can interact with multiple melanocortin receptor subtypes. Its activity at MC1R is associated with melanin production, while central activity involving MC3R and MC4R has generated research interest in appetite, energy balance, and sexual-arousal pathways. Pasted text

The Atlas Longevity Melanotan II pen contains 10 mg in a 3 mL pre-mixed cartridge with 300 total units/clicks.

Melanotan II remains an unapproved investigational peptide. It should not be presented as an approved treatment for tanning, obesity, sexual dysfunction, metabolic disorders, photoprotection, or other medical conditions. Pasted text


Clinical / Research Status

Melanotan II has been investigated in human, animal, observational, and laboratory research.

Evidence Type Status Based on Supplied Material
Human controlled research Yes
Human observational research Yes
Animal research Yes
In-vitro research Yes
Regulatory therapeutic approval No

The supplied material specifically states that Melanotan II remains a research peptide and is not approved for therapeutic use. Pasted text

Human research demonstrating biological activity should therefore not be interpreted as evidence of approved or established medical use.


Evidence Type

The supplied research material includes:

  • early human pigmentation studies;
  • observational sexual-response research;
  • rodent hypothalamic models;
  • melanocyte cultures;
  • metabolic animal research;
  • pharmacokinetic studies;
  • behavioural neurobiology models. Pasted text

The strength of evidence differs considerably depending on the proposed effect.

Pigmentation and melanocortin-receptor activity have more direct experimental support than broad claims involving mood, longevity, systemic recovery, or anti-ageing.


Mechanism of Action

Melanotan II interacts with several members of the melanocortin receptor family.

MC1R and Pigmentation

Activation of MC1R on melanocytes stimulates intracellular cAMP signalling and increases activity of enzymes involved in melanin production, including tyrosinase.

This can increase melanogenesis and skin pigmentation in experimental models.

MC3R and MC4R Signalling

Melanotan II also interacts with central melanocortin receptors, particularly MC3R and MC4R.

These receptors participate in pathways associated with:

  • appetite;
  • energy balance;
  • sexual arousal;
  • neuroendocrine signalling.

The cyclic structure of Melanotan II contributes to greater stability and receptor activity compared with endogenous α-MSH. Pasted text

Because Melanotan II is not highly selective for one receptor, its biological effects can extend beyond pigmentation.


Potential Benefits / Research Areas

Melanogenesis and Pigmentation Research

The primary research use of Melanotan II involves MC1R activation and melanin synthesis.

Experimental studies have reported increased melanocyte activity and pigmentation following exposure to Melanotan II. Pasted text

This does not establish Melanotan II as an approved cosmetic tanning product.

UV-Response and Photobiology Research

Melanin participates in the skin’s natural response to ultraviolet radiation.

Increased eumelanin production has therefore generated research interest in:

  • UV-response biology;
  • oxidative skin stress;
  • pigmentation adaptation;
  • photoprotection mechanisms. Pasted text

Melanotan II should not be represented as a substitute for sunscreen, protective clothing, or established UV-protection measures.

Appetite and Energy-Balance Research

MC4R is an important regulator of appetite and energy homeostasis.

Preclinical Melanotan II research has reported changes in:

  • food intake;
  • body weight;
  • energy expenditure;
  • lipid metabolism. Pasted text

These findings do not establish Melanotan II as an approved weight-loss treatment.

Sexual-Function Research

Central melanocortin signalling is involved in sexual arousal and erectile physiology.

Melanotan II has been investigated experimentally for its effects on:

  • sexual arousal;
  • erectile responses;
  • libido-related pathways;
  • reproductive behaviour. Pasted text

This activity is biologically meaningful but also contributes to potential adverse effects such as prolonged erections.

Neuroendocrine Research

Because Melanotan II interacts with central melanocortin receptors, it is also studied in neuroendocrine and behavioural models.

The supplied material discusses possible effects involving dopaminergic, serotonergic, reward, motivation, and emotional pathways. Pasted text

These areas should be described cautiously because the evidence does not establish Melanotan II as a treatment for mood or neurological disorders.

Inflammatory and Oxidative-Stress Research

The supplied source also describes experimental research involving melanocortin signalling and:

  • inflammatory cytokines;
  • TNF-α;
  • IL-1β;
  • reactive oxygen species;
  • antioxidant activity. Pasted text

These findings remain primarily mechanistic or preclinical.

Metabolic Research

Melanotan II’s effects on hypothalamic melanocortin pathways have made it useful in experimental metabolic research.

Areas investigated include:

  • appetite regulation;
  • glucose handling;
  • insulin-related pathways;
  • lipid oxidation;
  • energy expenditure. Pasted text

These effects should not be translated into guaranteed fat-loss or metabolic benefits in humans.


Research Data

Study / Model Reported Finding
Early human clinical research Increased skin pigmentation intensity and duration
Human observational research Changes in erectile response and libido-related signalling
Rodent hypothalamic models Reduced food intake and body weight through central melanocortin pathways
In-vitro melanocyte cultures Increased tyrosinase activity and melanin synthesis
Rat metabolic studies Increased energy expenditure and lipid-oxidation markers
Pharmacokinetic studies Greater stability and receptor persistence than endogenous α-MSH
Behavioural neurobiology models Changes in central signalling associated with arousal and behaviour

These results span human, animal, and cellular research, so findings from one model should not automatically be generalized to another. Pasted text


Potential Stack / Combination Research

The supplied material discusses experimental combinations involving:

  • Melanotan II + PT-141;
  • Melanotan II + GHK-Cu. Pasted text

Because PT-141 and Melanotan II both interact with melanocortin pathways, combining them could theoretically increase overlapping biological effects as well as adverse effects.

The supplied evidence does not establish validated human safety, compatibility, efficacy, or dosing for these combinations.

Atlas Longevity therefore does not present them as recommended stacks.


Atlas Longevity Melanotan II Pen Dosage / Click Chart

The Atlas Longevity Melanotan II pen contains:

10 mg Melanotan II

3 mL cartridge volume

300 total clicks

1 click = 0.01 mL

Maximum selectable dial amount = 60 clicks

Pen Specification

Pen Strength Volume Concentration Amount Per Click
10 mg 3 mL ≈3.333 mg/mL ≈0.0333 mg / 33.3 mcg

Concentration Calculation

10 mg ÷ 3 mL = 3.3333 mg/mL

Rounded:

≈3.333 mg/mL

Amount Per Click

10 mg ÷ 300 clicks = 0.033333 mg per click

Therefore:

1 click ≈0.0333 mg

or:

≈33.3 mcg Melanotan II


Melanotan II Click Conversion Chart

Clicks Volume Melanotan II Amount
1 0.01 mL ≈0.0333 mg / 33.3 mcg
5 0.05 mL ≈0.1667 mg / 166.7 mcg
10 0.10 mL ≈0.333 mg / 333 mcg
15 0.15 mL 0.500 mg / 500 mcg
20 0.20 mL ≈0.667 mg / 667 mcg
30 0.30 mL 1.000 mg
40 0.40 mL ≈1.333 mg
45 0.45 mL 1.500 mg
50 0.50 mL ≈1.667 mg
60 0.60 mL 2.000 mg

Useful Conversions

  • 15 clicks = 0.50 mg
  • 30 clicks = 1 mg
  • 45 clicks = 1.50 mg
  • 60 clicks = 2 mg

The maximum selectable amount in one dial operation is:

60 clicks = 0.60 mL = 2 mg Melanotan II

This is a mathematical concentration conversion and not a dosing recommendation.


Protocol / Dosage Information

The supplied source describes experimental quantities ranging approximately from 0.25 mg to 1 mg across pigmentation, libido, and metabolic research examples. Pasted text

Those original click calculations were based on a different 10 mg / 2 mL formulation, so they do not apply to the Atlas Longevity 3 mL pen.

Using the Atlas 10 mg / 3 mL / 300-click formulation:

Source-Referenced Amount Atlas Pen Mathematical Equivalent
0.25 mg ≈7.5 clicks*
0.50 mg 15 clicks
0.75 mg ≈22.5 clicks*
1.00 mg 30 clicks

*These quantities do not correspond exactly to whole pen clicks.

The source also provides frequency, timing, duration, and maintenance schedules. Those should not be carried into Atlas content as self-administration instructions.

The table above is provided only to translate quantities appearing in the source into Atlas concentration mathematics.


Possible Side Effects

Melanotan II has a more significant adverse-effect profile than should be implied by simple descriptions such as “mild and reversible.”

The supplied material reports potential effects including:

  • nausea;
  • vomiting;
  • facial flushing or warmth;
  • appetite suppression;
  • darkening of existing moles or freckles;
  • localized injection-site reactions;
  • spontaneous erections;
  • prolonged erections. Pasted text

Pigmentation Changes

Because Melanotan II stimulates melanogenesis, existing freckles, nevi, and other pigmented lesions may darken.

Changes in a mole should not automatically be assumed to be a normal or harmless tanning response.

Prolonged Erections / Priapism

Central melanocortin activity can affect erectile pathways.

The supplied scientific reference list includes a case report describing priapism associated with Melanotan use, which means prolonged erections should not be minimized as merely an expected research effect. Pasted text

Systemic Safety Concerns

The reference list also includes observational reports involving systemic toxicity, rhabdomyolysis, and renal infarction associated with Melanotan II exposure. Pasted text

Case reports do not establish how frequently these events occur or prove causation in every instance, but they are important safety signals and should not be omitted when presenting the compound responsibly.

The supplied evidence does not establish complete safety regarding:

  • long-term systemic exposure;
  • cardiovascular effects;
  • renal effects;
  • interactions with other melanocortin compounds;
  • repeated high exposure;
  • pregnancy or reproductive exposure;
  • dermatological risk;
  • unregulated combination protocols.

Product Attributes

Attribute Information
Compound Name Melanotan II
Common Abbreviation MT-II / MT-2
CAS Number 121062-08-6
Molecular Formula C50H69N15O9
Amino Acid Sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
Molecular Weight 1024.18 g/mol
PubChem CID 92432
Half-Life listed by source Approximately 30–60 minutes
Compound Type Synthetic cyclic α-MSH analogue
Research Focus Pigmentation, melanocortin signalling, sexual-function and metabolic research

These specifications are reported in the supplied reference material.

Included in the Box

Each Atlas Longevity product is carefully packed to support secure storage, clean handling, and convenient research use. Inside the package, you’ll find the essential items needed for organized laboratory handling:

  • 1× Ready-to-Use Injection Pen
  • 10× Ultra-Fine Needles (33G, 4 mm)
  • 10× Alcohol Prep Pads
  • Protective Foam Insert to help keep the pen secure during transport
  • Quick-Reference Instruction Panel inside the packaging
  • Tamper-Evident Security Seal for added package protection

Each component is arranged in a clean, protective presentation designed to keep the product secure and easy to access.

Storage

Storage conditions should follow the instructions supplied specifically with the Atlas Longevity Melanotan II formulation.

The reference product provides refrigeration and stability specifications for its own finished formulation. Those conditions should not automatically be transferred to Atlas Longevity without formulation-specific stability evidence.

Follow the temperature requirements, light-protection guidance, handling instructions, and shelf-life information printed on the Atlas Longevity product label or accompanying documentation.

The source also lists NDP-α-MSH among its synonyms. Because melanocortin analogue nomenclature can overlap, Atlas should confirm the exact compound identity against its COA before publishing all synonym data.

 


Frequently Asked Questions

What is Melanotan II?

Melanotan II is a synthetic cyclic analogue of alpha-melanocyte-stimulating hormone.

It interacts with several melanocortin receptor subtypes and is studied primarily for pigmentation, melanocortin signalling, appetite-related pathways, and sexual-function research. Pasted text

How does Melanotan II work?

Melanotan II activates melanocortin receptors.

MC1R activation increases melanocyte signalling and melanin synthesis, while activity at MC3R and MC4R contributes to central effects involving appetite, energy balance, and sexual arousal. Pasted text

Is Melanotan II the same as Melanotan I?

No.

Both compounds are synthetic melanocortin analogues, but they have different molecular structures and receptor profiles.

Melanotan II has broader activity across multiple melanocortin receptors, while Melanotan I / Afamelanotide is generally associated with greater MC1R selectivity.

Is Melanotan II approved?

No.

The supplied material identifies Melanotan II as an experimental research peptide that is not approved for therapeutic use. Pasted text

Is Melanotan II approved for tanning?

No regulatory approval for cosmetic tanning is established by the supplied material.

Its melanogenic effects have been investigated experimentally, but this does not make it an approved tanning treatment.

What is Melanotan II researched for?

Research areas include:

  • melanogenesis;
  • pigmentation;
  • MC1R signalling;
  • MC3R and MC4R signalling;
  • appetite regulation;
  • energy balance;
  • sexual arousal;
  • neuroendocrine biology;
  • metabolic research.

The strength of evidence varies significantly between these areas.

Has Melanotan II been studied in humans?

Yes.

The supplied material references early human pigmentation studies and observational research alongside animal and in-vitro studies. Pasted text

Human investigation does not mean that the compound is approved or proven safe for routine use.

Does Melanotan II increase pigmentation?

Human and laboratory studies described in the supplied source report increased melanogenesis and skin pigmentation through melanocortin-receptor activation. Pasted text

Does Melanotan II protect against UV exposure?

Increased eumelanin is relevant to natural photobiology, but Melanotan II should not be used as a substitute for sunscreen or established UV-protection measures.

The source does not establish that using the peptide makes intentional UV exposure safe.

Does Melanotan II affect appetite?

Preclinical research indicates that activity at central melanocortin receptors, particularly MC4R, can influence appetite and energy balance. Pasted text

This does not establish Melanotan II as an approved weight-management medicine.

Does Melanotan II affect libido?

Research has reported effects on sexual-arousal and erectile pathways associated with central melanocortin signalling. Pasted text

These effects can also produce adverse responses, including prolonged erections.

How much Melanotan II is in each Atlas Longevity pen?

Each Atlas Longevity Melanotan II pen contains:

10 mg in 3 mL.

What is the concentration of the Melanotan II pen?

The concentration is:

10 mg ÷ 3 mL = approximately 3.333 mg/mL

How many clicks are in the pen?

Each Atlas Longevity pen contains:

300 total clicks / units

with:

1 click = 0.01 mL

How much Melanotan II is in one click?

Each click contains approximately:

0.0333 mg

or:

33.3 mcg Melanotan II

How many clicks equal 0.5 mg?

15 clicks = 0.50 mg.

How many clicks equal 1 mg?

30 clicks = 1 mg.

These are mathematical concentration conversions rather than dosing recommendations.

What is the maximum selectable amount on the Melanotan II pen?

The maximum single dial selection is:

60 clicks

which equals:

0.60 mL

and:

2 mg Melanotan II

This describes the mechanical range of the pen rather than a recommended amount.

How long does a Melanotan II pen last?

The full cartridge contains:

300 clicks and 10 mg Melanotan II.

The number of administrations depends on the number of clicks selected each time.

For cartridge-capacity calculation only:

  • 5 clicks at a time = 60 administrations
  • 10 clicks at a time = 30 administrations
  • 15 clicks at a time = 20 administrations
  • 20 clicks at a time = 15 administrations
  • 30 clicks at a time = 10 administrations
  • 60 clicks at a time = 5 administrations

These examples describe cartridge capacity only.

Does the medication disappear when the dial returns to zero?

No.

After administration, the dial returns to zero while the remaining formulation stays inside the cartridge.

The unused Melanotan II remains in the pen until all 300 units have been used.

Can Melanotan II darken moles and freckles?

Yes, darkening of existing freckles and nevi is reported in the supplied material. Pasted text

Any unusual or concerning change in a pigmented lesion should not automatically be dismissed as normal pigmentation.

Can Melanotan II cause prolonged erections?

The supplied material reports spontaneous erections, and its reference list includes a case report involving priapism. Pasted text Pasted text

This is an important potential adverse effect rather than a desirable or guaranteed outcome.

Are there serious adverse-event reports involving Melanotan II?

Yes.

The supplied scientific-reference list includes observational reports involving systemic toxicity, rhabdomyolysis, renal infarction, and priapism. Pasted text

These reports do not establish incidence rates, but they are relevant safety signals.

Can Melanotan II be combined with PT-141?

The source discusses this as an experimental research concept because both compounds influence melanocortin signalling. Pasted text

However, overlapping receptor activity could also increase adverse effects, and validated human combination safety or dosing is not established.

Is there an established human dosage for Melanotan II?

The supplied material contains experimental quantities, but Melanotan II is not an approved therapeutic product and there is no universal approved human dosing standard established by the source.

The Atlas click chart therefore represents concentration mathematics only.

How should the Atlas Longevity Melanotan II pen be stored?

Follow the storage instructions supplied with the actual Atlas Longevity formulation.

The reference product’s refrigeration and stability claims relate to its own finished formulation and should not automatically be applied to Atlas without product-specific stability evidence.